Invitae: Michael Korn
Invitae appointed Michael Korn as its chief medical officer for oncology, effective March 13. Korn previously served as CMO at Caris Life Sciences and remains on the faculty at the University of California, San Francisco as a volunteer clinical professor in the division of hematology/oncology. At UCSF, he founded and led the Precision Oncology Initiative and the molecular tumor board and was the lead investigator of clinical trials exploring new treatments for advanced cancers. He obtained his medical degree from the Philipps University Marburg and graduated from the University of Düsseldorf in Germany. He completed his internal medicine and medical oncology training at the West German Cancer Center - University Hospital Essen.